Transient Infrared Imaging for Early Detection of Skin Cancer

Status

UNKNOWN

Phases

Phase 1Phase 2

Study type

Interventional

Source

ClinicalTrials.gov

Registry ID

NCT02154451

Enrollment

400

Registered

2014-06-03

Start date

2013-08-31

Completion date

Unknown

Last updated

2014-06-03

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Skin Cancer

Brief summary

The hypothesis or study goal is to determine whether functional dynamic infrared imaging can be used for melanoma and other skin cancer screening and/or diagnosis.

Interventions

DEVICEInfrared Imaging Device- ALIAS

Infrared Camera

Study design

Allocation

Intervention model

SINGLE_GROUP

Primary purpose

SCREENING

Masking

SINGLE (Investigator)

Eligibility

Sex/Gender

ALL

Age

18 Years to No maximum

Inclusion criteria

* All lesion in easily accessible places * Lesion less than 3.5 cm

Exclusion criteria

* Any minors * Lesion close to vital organs

Design outcomes

Primary

Measure	Time frame	Description
To detect skin cancers with >90% sensitivity and >50% specificity using infrared imaging	5 years	We are developing a screening algorithm than can compute data from infrared pictures and give us a threshold below which all the cases are benign and above which is malignant. Our primary outcome is to detect all the malignant cases with more than 90% sensitivity and all the benign cases with more than 50% specificity,

Countries

United States

Contacts

Primary ContactSanchita Krishna, PhD

sanchita@skinfrared.com505 453 3349

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026